Drug Type Small molecule drug |
Synonyms- |
Mechanism Alpha-amylase inhibitors, α-glucosidase inhibitors(Acidic alpha-glucosidase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Preclinical | EG | 01 Jan 2024 | |
Diabetes Mellitus, Type 2 | Preclinical | SA | 01 Jan 2024 |